张廷梅,熊敏,陈静
ZHANG Tingmei,XIONG Min,CHEN Jing

• 1:贵阳市公共卫生救治中心

摘要(Abstract)：

目的:了解耐多药结核病(MDR-TB)患者对抗结核药物的依从性。方法:选择76例MDR-TB并接受二线抗结核药物治疗的患者,采用阿米卡星(Am)及左氧氟沙星(Lfx)为核心药物的4种抗结核药物联合治疗方案,期间给予督导干预,比较治疗前后(治疗后6月、12月及18月)MDR-TB患者对抗结核治疗的依从性,同时观察患者的不良反应。结果:与治疗前比较,治疗后6月、12月及18月MDR-TB患者的依从性明显提高,差异有统计学意义(P<0.001);治疗后组间比较,差异无统计学意义(P>0.05);患者对抗结核治疗依从性差的主要原因是药物不良反应及对疾病认识不足,不良反应以抗结核药物注射局部皮下硬结、皮肤红染、血尿酸高、关节疼痛疼痛及肝功能损害为主。结论:加强对MDR-TB患者治疗过程中的督导干预,可提高抗结核治疗的依从性。
Objective: To investigate the compliance of patients with multiple drug resistant tuberculosis( MDR-TB) to anti-tuberculosis drugs. Methods: 76 cases of patients with MDR-TB receiving treatment of second-line anti-tuberculosis drugs were selected and enrolled in the study. They received a combined drug treatment in which Amikacin( Am) and Levofloxacin( Lfx) were core drugs combined with other 2 anti-tuberculosis drugs. During the treatment period,supervisory intervention was given.The MDR-TB patients ' compliance to anti-tuberculosis treatment was compared between before treatment and after treatment( 6 months,12 months,18 months after treatment) and meanwhile the adverse reactions in patients were observed. Results: Compared with before treatment,the patients' compliance to anti-tuberculosis treatment 6 months,12 months,18 months after treatment was significantly increased( P < 0. 001). There was no statistical difference in patients' compliance between groups after treatment( P > 0. 05). The main reasons for poor compliance of patients to anti-tuberculosis treatment were drug adverse reaction and lack of awareness of the disease. Adverse reactions were mainly localized subcutaneous induration caused by injection of anti-tuberculosis drugs,skin irritation,high uric acid in the blood,joint pain and liver function damage. Conclusion: To strengthen the supervision and intervention in the treatment of MDR-TB patients can improve the patients' compliance to anti-tuberculosis treatment.

关键词(KeyWords)： 结核;抗结核药;抗药性,多药;依从性
tuberculosis;anti tuberculosis drugs;drug tolerance;multi drug;compliance

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 张廷梅,熊敏,陈静
ZHANG Tingmei,XIONG Min,CHEN Jing

DOI: 10.19367/j.cnki.1000-2707.2016.05.027

参考文献(References)：

• [1]全国第五次结核病流行病学抽样调查技术指导组.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012(8):485-508.
• [2]李华平,杨坤云.耐多药肺结核病人治疗依从性分析及干预对策[J].实用预防医学,2009(5):1559-1661.
• [3]中国防痨协会.耐药结核病化学治疗指南(2015)[J].中国防痨杂志,2015(5):421-469.
• [4]王黎霞,徐彩红,陈明亭,等.我国开展耐多药肺结核诊疗管理的可行性分析[J].中国卫生资源,2012(4):325-327.
• [5]郦桂青,高翠南,何庆秋.肺结核病患者治疗依从性的研究进展[J].中国防痨杂志,2010(9):585-587.
• [6]张廷梅,骆科文,张晓均,等.产生复治后耐多药肺结核病的有关因素及临床特点[J].中国防痨杂志,2004(5):277-279.
• [7]曾安津,董霞.肺结核患者抗结核药物治疗不良反应[J].临床肺科杂志,2012(12):2226-2227.
• [8]罗晓媛,吴新荣.吡嗪酰胺致高尿酸血症[J].实用药物与临床,2013(3):270.
• [9]陈成伟.药物性肝损伤的发病机制及其处理[J].中华结核和呼吸杂志,2013(10):726-727.
• [10]戈启萍,王庆枫,段鸿飞,等.含丙硫异烟胺和对氨基水杨酸治疗方案发生药物性肝损伤129例临床分析[J].中华结核和呼吸杂志,2013(10):737-740.

文章评论(Comment)：